H.H. Freedman et al., “An Improved Williamson Ether Synthesis Using Phase Transfer Catalysis,” Tetrahedron Letters No. 38, pp. 3251-3254, 1997(**). |
T. Nishi et al., “Studies on 2-Oxoquinoline Derivatives as Blood Platelet Aggregation Inhibitors. II. 6-[3(1-Cyclohexyl-5-Tetrazolyl) Propoxy]-1,2-Dihydro-2-Oxoquinoline and Related Compounds”, Chem. Pharm. Bull., vol. 31, No. 4, pp. 1151-1157, (1982) (**). |
The Summary of the 29th Symposium on the Chemistry of Natural Products, pp. 41-43 (1994) (English translation of the Certificate and partial English translation are attached thereto.). |
Nishi, CA 99:98806, abstract of Chem & pharm bull, 1983, 31(4), 1151-1157.* |
Nishi, CA 103:141893, abstract of Chem & Pharm Bull, 1985, 33(3), 1140-1147.* |
The Summary of the 29th Symposium on the Chemistry of Natural Products, pp. 41-43 (1994) (full English translation). |
Japanese Pharmaceutical Codex, p. 836839 (1997) (full English translation). |
Starks; Liotta; Phase Transfer Catalysis, Academic Press: NY, 1978, pp. 128-138. |
Weber; Gokel; Phase Transfer Catalysis in Organic Synthesis, Springer: NY, 1977, pp. 73-84. |
A. Mckillop; J.C. Fiaud; R.P. Hug, Tetrahedron, vol. 30, p. 1379-1382 (1974). |
P.M. Quan; S.R. Kron, C.A. vol. 86, 189 480 (1977). |
J.D. Reinheimer, J.P. Douglass, H. Leister, M.B. Voelkel, J. Org. Chem., vol. 22, p. 1743-1745 (1957). |
B.R. Baker, F.J. McEvoy, J. Org. Chem., vol. 20, p. 136-142 (1955). |
A. Cohen, J.W. Haworth, E.H. Hughes, J. Chem. Soc., p. 4374-4383 (1952). |
J. Ugelstad, T. Ellingsen, A. Berge, Acta Chem. Scand. vol. 20, p. 1593-1598 (1966). |
R.L. Merker, M.J. Scott, J. Org. Chem. vol. 26, p. 5180-5182 (1961). |
J. March, Advanced Organic Chemistry, Fourth Edition, John Wiley & Sons: NY, 1992, pp. 362-365, pp. 386-387. |
T. Nishi et al., “Studies on 2-oxoquinoline Derivatives as Blood Platelet Aggregation Inhibitors. I. alkyl 4-(2-Oxo-1,2,3,4-tetrahydro-6-quinolyloxy) butyrates and related compounds”, Chem. Pharm. Bull., vol. 31, No. 3, pp. 798-810, (1983). |
Nishi et al.; “Studies on 2-Oxoquinoline Derivatives as Blood Platelet Aggregation Inhibitors. II. 6-[3-(1-Cyclohexyl-5-Tetrazolyl)Propoxy]-1,2-Dihydro-2-Oxoquinoline and Related Compounds”; Chem. Pharm. Bull., vol. 31, No. 4, pp. 1151-1157, (1983). |
Freedman et al.; “An Improved Williamson Ether Synthesis Using Phase Transfer Catalysis”; Tetrahedron Letters No. 38, pp 3251-3254, 1975. |
Chin-Hsien et al., “The Use of Phase-Transfer Catalysis For The Synthesis of Phenyl and 8-Quinolinyl Ethers,” Synthesis, pp. 858-861 (1982). |
G. Bram et al., “Solid-Liquid Phase Transfer Catalysis Without Solvent: A Mild And Efficient Preparation Of Mono And Di-Ethers Derived From 8-Hydroxyquinoline,” Synthetic Communications, 14(9), pp. 889-898 (1984). |
Japanese Pharmaceutical Codex, p. 836-839 (1997) (Partial English translation is attached thereto.). |
The Merck Index, p. 382 (1996). |
A.P. Bashall et al., “A Convenient, High-Yielding Method For The Methylenation of Catechols,” Tetrahedron Letters, No. 40, pp. 3489-3490 (1975). |
U.S. application No.: 60/225,362, “Novel synthesis for preparing cilostazol”, Mendelovichi, M. et al., Aug. 14, 2002. |
U.S. application No.: 10/208,738, “Process for producing carbostyril derivatives”, Aki, S. et al., Aug. 1, 2002. |